Authors:
MONNET I
BRIENZA S
HUGRET F
VOISIN S
GASTIABURU J
SALTIEL JC
SOULIE P
ARMAND JP
CVITKOVIC E
DECREMOUX H
Citation: I. Monnet et al., PHASE-II STUDY OF OXALIPLATIN IN POOR-PROGNOSIS NONSMALL CELL LUNG-CANCER (NSCLC), European journal of cancer, 34(7), 1998, pp. 1124-1127
Authors:
BRAIN E
SOULIE P
DELALANDE B
BERNARD A
BANAL A
MAHE E
CVITKOVIC F
ROUESSE J
RAMBERT P
Citation: E. Brain et al., INTENSIFIED ALTERNATING CHEMOTHERAPY (CT) AND RADIOTHERAPY (RT) FOR STAGE-III-IV HEAD-AND-NECK-CANCER (HNC) PATIENTS (PTS), Annals of oncology, 9, 1998, pp. 365-365
Authors:
DECREMOUX H
BEKRADDA M
MONNET I
SOULIE P
SALTIEL S
MISSET JL
FANDI A
BENSMAINE MA
CVITKOVIC E
Citation: H. Decremoux et al., UPDATE OF THE OXALIPLATIN (L-OHP) NAVELBINE (NVB) PHASE I/II MULTICENTRIC TRIAL IN PATIENTS (PTS) WITH ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC)/, Annals of oncology, 9, 1998, pp. 474-474
Authors:
GERMANN N
SOULIE P
BRIENZA S
ROTARSKY M
EMILE JF
DIPALMA M
MUSSET M
REYNES M
CVITKOVIC E
MISSET JL
Citation: N. Germann et al., OXALIPLATIN (LOHP) - A NEW PLATINUM ANALOG ACTIVE ON REFRACTORY RELAPSED NON-HODGKINS-LYMPHOMA/, Annals of oncology, 9, 1998, pp. 528-528
Authors:
FUMOLEAU P
TUBIANAHULIN M
SOULIE P
DELECROIX V
SISTAC F
MEFTI F
SOULAS F
APPIA F
LEBECQ A
VERGNIOL JC
VERNILLET L
RIVA A
Citation: P. Fumoleau et al., A DOSE-FINDING AND PHARMACOKINETIC (PK) PHASE-I STUDY OF A NEW FORMULATION OF DOCETAXEL (D) IN ADVANCED SOLID TUMORS, Annals of oncology, 9, 1998, pp. 387-387
Authors:
DECREMOUX H
BEKRADDA M
MONNET I
SOULIE P
SALTIEL S
MISSET JL
FANDI A
BENSMAINE MA
CVITKOVIC E
Citation: H. Decremoux et al., UPDATE OF THE OXALIPLATIN (L-OHP) NAVELBINE (NVB) PHASE I/II MULTICENTRIC TRIAL IN PATIENTS (PTS) WITH ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC)/, Annals of oncology, 9, 1998, pp. 446-446
Authors:
BEKRADDA M
CHATELUT E
CVITKOVIC E
SOULIE P
CANAL P
MISSET JL
DUPONTANDRE G
BENSMAINE MA
BUGAT R
Citation: M. Bekradda et al., PHARMACOKINETICS (PK) AND PHARMACODYNAMICS OF THE CARBOPLATIN (CBDCA)OXALIPLATIN (L-OHP) COMBINATION IN PATIENTS (PTS) WITH ADVANCED MALIGNANCIES - PRELIMINARY-RESULTS OF AN ONGOING PHASE-I TRIAL/, Annals of oncology, 9, 1998, pp. 447-447
Authors:
BOURGEOIS H
TURPIN F
BOUCHADA M
VOLTERS A
CVITKOVIC F
GOUPIL A
JANVIER M
TUBIANAHULIN M
SOULIE P
BERLIE J
GIRARD M
ROUESSE J
Citation: H. Bourgeois et al., MITOMYCIN-VINORELBINE AS 2ND LINE CHEMOTHERAPY IN METASTATIC BREAST-CANCER, Bulletin du cancer, 85(9), 1998, pp. 794-798
Authors:
SOULIE P
BENSMAINE A
GARRINO C
CHOLLET P
BRAIN E
FERERES M
JASMIN C
MUSSET M
MISSET JL
CVITKOVIC E
Citation: P. Soulie et al., OXALIPLATIN CISPLATIN (L-OHP/CDDP) COMBINATION IN HEAVILY PRETREATED OVARIAN-CANCER/, European journal of cancer, 33(9), 1997, pp. 1400-1406
Authors:
TRANDAFIR L
RUFFIE P
BOREL C
MONNET I
SOULIE P
ADAMS D
CVITKOVIC E
ARMAND JP
Citation: L. Trandafir et al., HIGHER DOSES OF ALPHA-INTERFERON DO NOT INCREASE THE ACTIVITY OF THE WEEKLY CISPLATIN-INTERFERON COMBINATION IN ADVANCED MALIGNANT MESOTHELIOMA, European journal of cancer, 33(11), 1997, pp. 1900-1902
Authors:
SOULIE P
TRANDAFIR L
TAAMMA A
LOKIEC F
BRAIN E
DELORD JP
MITA A
VANNETZEL JM
CVITKOVIC E
MISSET JL
Citation: P. Soulie et al., SCHEDULE-DEPENDENT PACLITAXEL TOLERANCE ACTIVITY - DATA FROM A 7 DAY INFUSION PHASE-I STUDY WITH PHARMACOKINETICS IN PACLITAXEL REFRACTORY OVARIAN-CANCER/, Anti-cancer drugs, 8(8), 1997, pp. 763-766
Authors:
BRAIN ECG
MITA A
SOULIE P
ERRIHANI H
BESSARD ACH
CHAOUCHE M
ALEXANDRE J
DELORD JP
CVITKOVIC E
JASMIN C
MISSET JL
Citation: Ecg. Brain et al., 6-DAY CONTINUOUS-INFUSION OF HIGH-DOSE IFOSFAMIDE WITH BONE-MARROW GROWTH-FACTORS IN ADVANCED REFRACTORY MALIGNANCIES, Journal of cancer research and clinical oncology, 123(4), 1997, pp. 227-231
Citation: Jc. Halle et al., EVALUATION OF THE ELECTRON-WITHDRAWING CH ARACTER OF THE 4-NITROBENZOFURAZANYL MOIETY - IONIZATION OF 7-ANILINO-4-NITROBENZOFURAZANS, Canadian journal of chemistry, 75(9), 1997, pp. 1240-1247
Authors:
SOULIE P
RUFFIE P
TRANDAFIR L
MONNET I
TARDIVON A
TERRIER P
CVITKOVIC E
LECHEVALIER T
ARMAND JP
Citation: P. Soulie et al., COMBINED SYSTEMIC CHEMOIMMUNOTHERAPY IN ADVANCED DIFFUSE MALIGNANT MESOTHELIOMA - REPORT OF A PHASE I-II STUDY OF WEEKLY CISPLATIN INTERFERON ALFA-2A, Journal of clinical oncology, 14(3), 1996, pp. 878-885
Authors:
FARHAT F
CULINE S
LHOMME C
DUVILLARD P
SOULIE P
MICHEL G
TERRIERLACOMBE MJ
THEODORE C
SCHREINEROVA M
DROZ JP
Citation: F. Farhat et al., DESMOPLASTIC SMALL ROUND-CELL TUMORS - RESULTS OF A 4-DRUG CHEMOTHERAPY REGIMEN IN 5 ADULT PATIENTS, Cancer, 77(7), 1996, pp. 1363-1366
Citation: Jf. Llory et al., FEASIBILITY OF HIGH-DOSE PLATINUM DELIVERY WITH COMBINED CARBOPLATIN AND OXALIPLATIN, Journal of the National Cancer Institute, 86(14), 1994, pp. 1098-1099
Authors:
DEFORNI M
GUALANO V
CANAL P
MARTEL P
IZARSOUM F
CHEVREAU C
SOULIE P
ROCHE H
BUGAT R
Citation: M. Deforni et al., CONTINUOUS-INFUSION OF 5-FLUOROURACIL BY DOUBLE ROUTE (INTRAVENOUS AND INTRAPERITONEAL) WITH MODULATION BY FOLINIC ACID - CLINICAL AND PHARMACOKINETIC, PHASE-I STUDY IN PATIENTS WITH INTRAABDOMINAL MALIGNANCIES, Bulletin du cancer, 80(5), 1993, pp. 408-417